
The 3rd International Online Conference on Vaccines
Part of the International Electronic Conference on Vaccines series
26–28 November 2025



Vaccine Technology, Immunopathogenesis, Mucosal Vaccines, Vectored Vaccines, Vaccine Adjuvants, Vaccine Delivery, Immunotherapy, Cancer Vaccines
- Go to the Sessions
- Event Details
IOCV 2025 is open for submissions.
You can submit your abstract here. Register for FREE to IOCV 2025, which will take place on 26-28 November 2025!
Please register here by 23 November 2025.
Welcome from the Chair
S2. Vectored Vaccines;
S3. Models for Vaccine Development and Evaluation;
S4. New Approaches for Vaccine Adjuvants;
S5. New Methods for Vaccine Delivery;
S6. Cancer Vaccines and Immunotherapy.
Professor Sara Louise Cosby
School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, UK
Virology, Veterinary Sciences Division, Agri-Food and Biosciences Institute, UK
Event Chair

School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, UK
Virology, Veterinary Sciences Division, Agri-Food and Biosciences Institute, UK
Session Chairs

Prof. Dr. Mona O. Mohsen
Department of Biomedical Research, University of Bern, Bern, Switzerland

Prof. Dr. Srinivasa Reddy Bonam
1. Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA; 2. Bapatla College of Pharmacy, Bapatla, India

Prof. Dr. Silvio Tafuri
Interdisciplinary Department of Medicine, Aldo Moro University of Bari, Bari, Italy

Prof. Dr. Seth Pincus
Department of Chemistry and Biochemistry, Montana State University, Bozeman, USA

Prof. Dr. Jorge H. Leitão
Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal

Professor Peter Delputte
Department of Biomedical Sciences, University of Antwerp, Anvers, Belgium
Event Committees

Division of Biomedical and Life Sciences, Furness College, Lancaster University, Lancaster, UK

Department of Veterinary Biosciences, The Ohio State University, Columbus, USA

1. Department of Public Health, School of Health Sciences, Ashkelon Academic College, Ashkelon, Israel;,
2. School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheba, Israel

Department of Pharmacology, University of Minnesota, Minnesota, USA

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

Medical Management, Hygiene, Epidemiology and Hospital Infection, University Hospital of Sassari, Sassari, Italy

Department of Radiology, Michigan State University, East Lansing, USA

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, USA

Department of Public Health Policy, School of Public Health, University of West Attica, Greece
Dimitris Zavras is an Associate Professor of Health Services Research and Health Economics at the Department of Public Health Policy at the University of West Attica. He is also a faculty member of Hellenic Open University. Dimitris was born in Athens in 1968 and studied Physics at the National & Kapodistrian University of Athens. His postgraduate studies include an M.Sc. in Applied Physics from the University of Massachusetts; M.Sc. in Statistics from Athens University of Economics and Business; M.Sc. in Healthcare Management from the National School of Public Health and a Doctorate (Ph.D.) in Health Services Research and Health Economics from the University of Thessaly (Department of Economics). Dimitris has taught in postgraduate programs at the University of West Attica, the University of Peloponnese, the Neapolis University Pafos (Cyprus), and the National School of Public Health and in undergraduate programs at the University of West Attica, the University of Peloponnese and the Athens University of Applied Sciences. Dimitris Zavras’ research interests focus on healthcare access, utilization of healthcare services, healthcare provider choice, and unmet healthcare needs. His most recent research work and published articles address economic issues surrounding the COVID-19 pandemic. He is a member of the International Health Economics Association and the Hellenic Scientific Society of Health Economics and Health Policy. He is also a member of the Hellenic Society for Healthcare Services Management.

Division of Infectious Disease and International Medicine, Department of Internal Medicine, University of South Florida, Tampa, USA

Department of Veterinary Microbiology, Western College of Veterinary Medicine, Saskatoon, Canada

Laboratory of Microbiology, Democritus University of Thrace, Komotini, Greece

Université de Versailles Saint-Quentin-En-Yvelines, Boulogne-Billancourt, France

Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, USA

Vector Biology Section, Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, Maryland, USA

Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden

Department of Molecular Medicine, College of Medicine, Tampa, United States
Keynote Speakers

University and Hospital of Lausanne, Lausanne, Switzerland
Invited Speakers

Institute of Animal Pathology, University of Bern, Bern, Switzerland

University of Washington School of Medicine, Seattle, USA

Centre for Immuno-Oncology, University of Oxford, Oxford, UK
Registration
The registration for IOCV 2025 will be free of charge! The registration includes attendance to all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 23 November 2025.
Instructions for Authors
IOCV 2025 will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
Important Deadlines
- Deadline for abstract submission: 31 July 2025
- Announcement of oral and poster abstract results: 29 August 2025. You will be notified of the acceptance of an oral/poster presentation in a separate email.
Certificates of Participation are available in your logged-in area of Sciforum.net, under “My Certificates” after the conference.
1. The abstract structure should include the introduction, methods, results, and conclusions sections of about 200–300 words in length.
2. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
3. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
The slot for the oral presentation is 15 mins. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session. Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the abstract. Slides, if available, will be displayed directly on the website using the proprietary slide viewer at Sciforum.net. Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format prior to submission so that they can be converted for online display.
- Poster should include the title, authors, contact details and main research findings, as well as tables, figures and graphs where necessary.
- File format: PDF (.pdf).
- Size in pixel: 1080 width x 1536 height–portrait orientation.
- Size in cm: 38,1 width x 54,2 height–portrait orientation.
- Font size: ≥16.Examples of successful submissions can be viewed here at the following links: (1), (2), (3).
You can use our free template to create your poster. The poster template can be downloaded HERE.
Authors who wish to present a poster are invited to send it to the conference email at iocv2025@mdpi.com. All posters will be permanently exhibited online in the Poster Gallery.
It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflicts of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue (will be announced soon), published in Vaccines (ISSN 2076-393X, Impact Factor 5.2), with a 10% discount on the publication fee. Please note that no other discounts are applicable. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
All accepted abstracts will be published in the conference report of The 3rd International Online Conference on Vaccines in Medical Sciences Forum (ISSN: 2673-9992); if you wish to publish an extended proceeding paper (4-8 pages), please submit it to the same journal after the conference. There will be no additional fees.
Proceedings submission deadline: 15 January 2026.
Manuscripts for the proceedings issue must be formatted as follows:
Title
Full author names
Affiliations (including full postal address) and authors' e-mail addresses
Abstract
Keywords
Introduction
Methods
Results and Discussion
Conclusions
Acknowledgements
References.
IOCV 2025 Proceeding Paper Template
Event Awards
The Awards
Number of Awards Available: 6
The Best Poster Awards are given to the submission judged to make the most significant and interesting poster for the conference.
Sponsors and Partners
For information regarding sponsorship and exhibition opportunities, please click here.
Organizers
Media Partners
Conference Secretariat
Ms. Amy Chen
Ms. Quincy Zhang
Ms. Theodora Felegean
Email: iocv2025@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
S5. New Methods for Vaccine Delivery
Delivery methods are an especially relevant topic to vaccination. While other drugs mainly need to account for penetration, absorption, and bioavailability, vaccines also have to take into consideration a patient’s comfort and the tolerability of specific delivery systems. Moreover, cultural and individual factors may lead specific populations to refuse some vaccination delivery methods, especially those that are based on animal-derived platforms and require injection via needles. In addition to this, some immunization products are not suitable for conventional tissue delivery methods, requiring specific platforms and administration methods in order to work. Therefore, for years, research has been focusing on the development of new vaccine delivery systems that make vaccination both more effective and tolerable, while also making altogether new products available. Examples of these new techniques include the use of microneedles, which allow for effective penetration while causing only minimal pain and dissimulating the presence of needles, or the inclusion of vaccine antigens within liposomes. Although based on conventional injection methods, the latter is especially promising both in the field of infectious disease prevention and in the development of cancer vaccines; new kinds of molecular engineering allow for improved liposomic penetration in cellular targets and minimal toxicity. This session will tackle this interesting topic, providing insights regarding the new delivery systems that are currently being developed or tested.
Session Chair
Prof. Dr. Silvio Tafuri, Interdisciplinary Department of Medicine, Aldo Moro University of Bari, Italy
S6. Cancer Vaccines and Immunotherapy
Vaccination against infectious diseases represents one of the most transformative achievements in medicine, effectively training the immune system to neutralize harmful pathogens and prevent disease. This principle has been extended to cancer vaccines, which aim to either prevent cancer-causing infections or eliminate existing cancer cells. Developing therapeutic vaccines against established solid tumors remains a significant challenge due to the immunosuppressive tumor microenvironment, the difficulty in identifying suitable targets, and the low immunogenicity of existing vaccines. Cancer immunotherapy represents a transformative approach in oncology, harnessing the power of the immune system to target and eliminate cancer cells, offering new hope for patients with previously untreatable malignancies.
This session will explore cutting-edge advancements in cancer vaccines and immunotherapy for solid and hematological tumors. We encourage innovative approaches using delivery platforms such as virus-like nanoparticles, mRNA, DNA, and adenoviruses, alongside novel coupling and genetic fusion techniques to enhance efficacy and precision. Contributions focusing on personalized or universal strategies are highly welcomed. Additionally, this year we will highlight projects investigating mechanisms of tumor immune evasion following vaccination or immunotherapy, novel approaches to advancing tumor antigen discovery, and the application of deep learning (DL)-based histology to analyze the spatial distribution of immune and tumor cells within the tumor microenvironment. With tumor immunology/immunotherapy increasingly focusing on optimizing vaccination strategies (neoadjuvant, adjuvant, and periadjuvant strategies) and various routes of vaccination (intratumor, intralymphatic, intranodal, intranasal, etc.), this will be a key area of discussion. Finally, the role of combination therapies and the contribution of diverse immune cells in mounting effective antitumor responses will be a central theme of this conference.
Session Chairs
Prof. Dr. Mona O. Mohsen, Department of Biomedical Research, University of Bern, Bern, Switzerland
Prof. Dr. Seth Pincus, Department of Chemistry and Biochemistry, Montana State University, Bozeman, USA